Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.

MLA

Fendler, Annika, et al. “Immune Responses Following Third COVID-19 Vaccination Are Reduced in Patients with Hematological Malignancies Compared to Patients with Solid Cancer.” Cancer Cell, vol. 40, no. 4, Apr. 2022, p. 438. EBSCOhost, https://doi.org/10.1016/j.ccell.2022.03.010.

APA

Fendler, A., Shepherd, S. T. C., Au, L., Wilkinson, K. A., Wu, M., Schmitt, A. M., Tippu, Z., Farag, S., Rogiers, A., Harvey, R., Carlyle, E., Edmonds, K., Del Rosario, L., Lingard, K., Mangwende, M., Holt, L., Ahmod, H., Korteweg, J., Foley, T., … Turajlic, S. (2022). Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer. Cancer Cell, 40(4), 438. https://doi.org/10.1016/j.ccell.2022.03.010

Chicago

Fendler, Annika, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Andreas M Schmitt, Zayd Tippu, et al. 2022. “Immune Responses Following Third COVID-19 Vaccination Are Reduced in Patients with Hematological Malignancies Compared to Patients with Solid Cancer.” Cancer Cell 40 (4): 438. doi:10.1016/j.ccell.2022.03.010.